Literature DB >> 2611233

Autoactivation of human recombinant coagulation factor VII.

A H Pedersen1, T Lund-Hansen, H Bisgaard-Frantzen, F Olsen, L C Petersen.   

Abstract

Single-chain human recombinant factor VII produced by transfected baby hamster kidney cells was purified to homogeneity in the presence of benzamidine. The amidolytic activity of single-chain recombinant factor VII with a peptidylnitroanilide substrate, methoxycarbonyl-D-cyclohexanylglycyl-L-arginine-p-nitroanilide, was less than 1% of that obtained with factor VIIa. Purified single-chain recombinant factor VII spontaneously activated in the absence of inhibitor. The activation reaction was enhanced by at least 2 orders of magnitude in the presence of a positively charged surface, provided either as an anion-exchange matrix or as poly(D-lysine). The progress curve for factor VIIa generation was sigmoidal. Benzamidine inhibits recombinant factor VIIa activity and factor VII activation with identical inhibition constants (Ki) of 11 mM. In contrast, benzamidine inhibition of bovine factor Xa and bovine factor IIa was observed at Ki values equal to 0.3 and 0.5 mM, respectively. Bovine factors Xa and IIa are known activators of factor VII and the most likely contaminants of our recombinant factor VII preparations. Single-chain recombinant factor VII purified from cells cultured in the absence of bovine serum activated at the same rate as factor VII from cells cultured in the presence of bovine serum. This also excluded the possibility that the activation reaction was caused by contaminating bovine proteases. On the basis of these observations, we propose that factor VII is autoactivated in vitro in the presence of a positively charged surface.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2611233     DOI: 10.1021/bi00450a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  The importance of residues 195-206 of human blood clotting factor VII in the interaction of factor VII with tissue factor.

Authors:  P Wildgoose; A L Kazim; W Kisiel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.

Authors:  S Dittmar; W Ruf; T S Edgington
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.

Authors:  A M Shah; W Kisiel; D C Foster; G L Nelsestuen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.

Authors:  Raffaella Toso; Mirko Pinotti; Katherine A High; Eleanor S Pollak; Francesco Bernardi
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

5.  Prostasin and hepatocyte growth factor B in factor VIIa generation: Serine protease knockdowns in zebrafish.

Authors:  Gauri Khandekar; Neha Iyer; Pudur Jagadeeswaran
Journal:  Res Pract Thromb Haemost       Date:  2020-09-22

6.  Analysis of the site-specific asparagine-linked glycosylation of recombinant human coagulation factor VLLa by glycosidase digestions, liquid chromatography, and mass spectrometry.

Authors:  N Kristian Klausen; S Bayne; L Palm
Journal:  Mol Biotechnol       Date:  1998-06       Impact factor: 2.695

Review 7.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

8.  Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.

Authors:  C A Sprecher; W Kisiel; S Mathewes; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Thrombin production and human neutrophil elastase sequestration by modified cellulosic dressings and their electrokinetic analysis.

Authors:  Judson Vincent Edwards; Nicolette Prevost
Journal:  J Funct Biomater       Date:  2011-12-15

10.  Electrokinetic and hemostatic profiles of nonwoven cellulosic/synthetic fiber blends with unbleached cotton.

Authors:  J Vincent Edwards; Elena Graves; Alvin Bopp; Nicolette Prevost; Michael Santiago; Brian Condon
Journal:  J Funct Biomater       Date:  2014-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.